Stock-Based Compensation (Details) (USD $)	3 Months Ended	9 Months Ended	1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended	1 Months Ended	9 Months Ended
	Sep. 30, 2013 Restricted Stock Awards	Sep. 30, 2013 Restricted Stock Awards	Mar. 31, 2013 Restricted Stock Awards Awarded in 2009 and 2010	Sep. 30, 2013 Stock options	Sep. 30, 2013 Stock options	Dec. 31, 2009 Stock options	Mar. 31, 2013 Stock options Awarded in 2009	Sep. 30, 2013 Stock options Awarded in 2009 item	Sep. 30, 2013 Plan
Share-Based Compensation
Number of shares authorized for grant									6,900,000
Number of shares of common stock exchanged for each award		1
Aggregate number of shares approved	5,033,333	5,033,333		2,410,465	2,410,465
Number of restricted stock units for which performance targets established (in shares)			178,335
Compensation expense	$ 1,500,000	$ 5,000,000		$ 500,000	$ 1,600,000
Unrecognized compensation cost related to the unvested awards	2,700,000	2,700,000		900,000	900,000
Weighted average period over which unrecognized compensation cost is expected to be recognized		2 years 1 month 6 days			2 years
Number of Shares
Granted and unvested, beginning of period (in shares)		1,141,666
Vested (in shares)		(514,999)
Granted (in shares)		196,668
Forfeited (in shares)		(66,667)
Total granted and unvested (in shares)	756,668	756,668
Approved for grant (in shares)	852,500	852,500
Total awarded and unvested, end of period (in shares)	1,609,168	1,609,168
Weighted Average Grant Date Fair Value
Total Granted and Unvested, beginning of period, weighted average grant date fair value (in dollars per share)		$ 18.12
Vested, weighted average grant date fair value (in dollars per share)		$ 20.72
Granted, weighted average grant date fair value (in dollars per share)		$ 19.27
Forfeited, weighted average grant date fair value (in dollars per share)		$ 14.23
Total Granted and Unvested, end of period, weighted average grant date fair value (in dollars per share)	$ 16.99	$ 16.99
Aggregate Intrinsic Value
Total Granted and Unvested, beginning of period, aggregate intrinsic value		15,641,000
Vested, aggregate intrinsic value		9,560,000
Granted, aggregate intrinsic value		4,193,000
Total Granted and Unvested, aggregate intrinsic value	16,132,000	16,132,000
Approved for grant, aggregate intrinsic value	18,175,000	18,175,000
Total Awarded and Unvested, end of period, aggregate intrinsic value	34,307,000	34,307,000
Vesting schedule of outstanding unvested restricted stock awards
2013 (in shares)	185,000	185,000
2014 (in shares)	546,668	546,668
2015 (in shares)	187,500	187,500
2016 (in shares)	202,500	202,500
2017 (in shares)	442,500	442,500
2018 (in shares)	36,000	36,000
2019 (in shares)	9,000	9,000
Total (in shares)	1,609,168	1,609,168
Number of unvested stock awards that will vest subject to the satisfaction of service-based requirements (in shares)		160,000
Number of unvested stock awards that will vest subject to the satisfaction of service-based requirements and the achievement of performance metrics (in shares)		1,449,168
Term of Stock Options					10 years
Number of stock option awards subject to achievement of pre-tax income performance targets (in shares)						750,000	150,000
Number of Shares
Total Granted and Outstanding, beginning of period (in shares)					1,315,465
Granted (in shares)					150,000
Exercised (in shares)					(40,465)
Forfeited (in shares)					(50,000)
Total granted and outstanding (in shares)				1,375,000	1,375,000
Approved for grant (in shares)				725,000	725,000
Total Awarded and Unvested, end of period (in shares)				2,100,000	2,100,000
Weighted Average Grant Date Fair Value
Total Granted and Outstanding, beginning of period, grant date value (in dollars per share)					$ 9.72
Granted, grant date value (in dollars per share)					$ 6.93
Exercised, grant date value (in dollars per share)					$ 6.18
Forfeited, grant date value (in dollars per share)					$ 7.25
Total Granted and Outstanding, end of period, grant date value (in dollars per share)				$ 9.61	$ 9.61
Weighted Average Exercise Price
Total granted and outstanding, beginning of period, weighted average exercise price (in dollars per share)					$ 18.91
Granted, weighted average exercise price (in dollars per share)					$ 20.33
Exercised, weighted average exercise price (in dollars per share)					$ 13.77
Total Granted and Outstanding, weighted average exercise price (in dollars per share)				$ 19.45	$ 19.45
Approved for grant, weighted average exercise price (in dollars per share)				$ 11.61	$ 11.61
Total Awarded and Outstanding, end of period, weighted average exercise price (in dollars per share)				$ 16.75	$ 16.75
Number of vested and exercisable stock options (in shares)				860,000	860,000
Vested and exercisable stock options, weighted average exercise price (in dollars per share)				$ 22.10	$ 22.10
Number of unvested stock option awards that will vest subject to the satisfaction of service-based requirements (in shares)				282,500	282,500
Number of unvested stock option awards that will vest subject to the satisfaction of service-based requirements and the achievement of performance metrics (in shares)				957,500	957,500
Intrinsic value of outstanding stock options				$ 3,800,000	$ 3,800,000
Weighted average remaining contractual term of outstanding stock options					5 years 9 months 18 days
Number of installments for vesting of stock awards								5
Key assumptions used in estimating the grant date fair values of stock option awards granted
Risk-free interest rate (as a percent)								0.48%
Expected life of options								3 years 7 months 6 days
Expected volatility of underlying stock (as a percent)								51.00%
Expected quarterly dividends (as a percent)								0.00%